MIRA INFORM REPORT

 

 

Report Date :

26.04.2013

 

IDENTIFICATION DETAILS

 

Name :

EMS SA

 

 

Registered Office :

Rod Jornalista Francisco Aguirre Proenca, S/Nº, Km,8 Bloco I, Ii E V - Chacara Assay, 13.186-901 - Hortolandia/Sp

 

 

Country :

Brazil

 

 

Financials (as on) :

31.12.2012

 

 

Date of Incorporation :

09.01.1964

 

 

Legal Form :

Privately Held Corporation

 

 

Line of Business :

Manufacturer of pharmaceuticals

 

 

No. of Employees :

4500

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory 

Payment Behaviour :

No  Complaints

Litigation :

Clear 

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 30th, 2012

 

Country Name

Previous Rating

(31.03.2012)

Current Rating

(30.06.2012)

Brazil

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

Brazil ECONOMIC OVERVIEW

 

Characterized by large and well-developed agricultural, mining, manufacturing, and service sectors, Brazil's economy outweighs that of all other South American countries, and Brazil is expanding its presence in world markets. Since 2003, Brazil has steadily improved its macroeconomic stability, building up foreign reserves, and reducing its debt profile by shifting its debt burden toward real denominated and domestically held instruments. In 2008, Brazil became a net external creditor and two ratings agencies awarded investment grade status to its debt. After strong growth in 2007 and 2008, the onset of the global financial crisis hit Brazil in 2008. Brazil experienced two quarters of recession, as global demand for Brazil's commodity-based exports dwindled and external credit dried up. However, Brazil was one of the first emerging markets to begin a recovery. In 2010, consumer and investor confidence revived and GDP growth reached 7.5%, the highest growth rate in the past 25 years. Rising inflation led the authorities to take measures to cool the economy; these actions and the deteriorating international economic situation slowed growth to 2.7% in 2011, and 1.5% in 2012. Despite slower growth, in 2011 Brazil overtook the United Kingdom as the world's seventh largest economy in terms of GDP. Unemployment is at historic lows and Brazil's traditionally high level of income inequality has declined for each of the last 14 years. Brazil's historically high interest rates have made it an attractive destination for foreign investors. Large capital inflows over the past several years have contributed to the appreciation of the currency, hurting the competitiveness of Brazilian manufacturing and leading the government to intervene in foreign exchange markets and raise taxes on some foreign capital inflows. President Dilma ROUSSEFF has retained the previous administration's commitment to inflation targeting by the central bank, a floating exchange rate, and fiscal restraint. In an effort to boost growth, in 2012 the administration implemented asomewhat more expansionary monetary policy that has failed to stimulate much growth.

 

Source : CIA


 

Company name

 

EMS S/A

 

 

cOMPANY ADDRESSES

 

MAIN ADDRESS:

ROD JORNALISTA FRANCISCO AGUIRRE PROENCA, S/Nº, KM,8 BLOCO I, II E V - CHACARA ASSAY

ZIP CODE/CITY:

13.186-901 - HORTOLANDIA/SP

 

 

PHONE:

19 3887-9961

E-MAIL:

joaodenadal@ems.com.br

WEB SITE:

www.ems.com.br

 

BRANCHES:

 

 

 

ADDRESS:

AVENIDA A,27 A, CJ MARCOS FREIRE II - TAICOCA

ZIP CODE/CITY:

49160-000 NOSSA SENHORA DO SOCORRO/SE

CNPJ:

57.507.378/0005-27

 

 

ADDRESS:

SAA NORTE, QUADRA 02,960

ZIP CODE/CITY:

70632-200 BRASÍLIA/DF

PHONE:

61 3363-4309

CNPJ:

57.507.378/0006-08

 

 

ADDRESS:

RUA MONSENHOR OTÁVIO DE CASTRO,167 - VILA UNIÃO

ZIP CODE/CITY:

60410-691 FORTALEZA/CE

CNPJ:

57.507.378/0007-99

 

 

ADDRESS:

RUA 1.126, QUADRA 230, LOTE 2, CASAS 1 E 2,0 - SETOR MARISTA

ZIP CODE/CITY:

74175-050 GOIÂNIA/GO

CNPJ:

57.507.378/0008-70

 

 

ADDRESS:

RUA COM CARLO MARIO GARDANO,450 - CENTRO

ZIP CODE/CITY:

09.720-47 SAO BERNARDO DO CAMPO/SP

PHONE:

11 2104-1677

CNPJ:

57.507.378/0001-01

STATE REGISTER:

635.038.454.114

 

 

ADDRESS:

268 MUNOZ RIVERA AVE, WESTERNBANK WORLD PLAZA, SUÍTE,808 - SAN JUAN

ZIP CODE/CITY:

PORTO RICO, PR 00918

 

 

ADDRESS:

RUA COMENDADOR CARLO MARIO GARDANO,450 - VILA SANTA RITA DE CÁSSIA

ZIP CODE/CITY:

09720-470 SÃO BERNARDO DO CAMPO/SP

CNPJ:

57.507.378/0001-01

 

LEGAL DATA

 

MAIN ACTIVITIES:

 

MANUFACTURE OF PHARMACEUTICALS.

 

LEGAL FORM:

PRIVATELY HELD CORPORATION

 

 

INCORPORATION DATE:

09/01/1964

REGISTER DATE:

09/01/1964

BALANCE SHEET FILING DATE:

31/12

TAX CONTRIBUTOR NUMBER(CNPJ):

57.507.378/0003-65

STATE REGISTER:

748.002.161.113

 

 

SHARE CAPITAL:

R$ 221.716.502,41

LAST REGISTER OF CAPITAL:

26/11/2012

 

BOARD OF DIRECTORS:

 

 

 

LUIZ CARLOS BORGONOVI

PRESIDENT DIRECTOR

CLARICE MITIE SANO YUI

VICE-PRESIDENT DIRECTOR

ISRAEL DOMINGUES BACCA

VICE-PRESIDENT DIRECTOR

MARIO DE SOUZA NOGUEIRA NETO

VICE-PRESIDENT DIRECTOR

 

 

AUTHORIZED USE OF SIGNATURE

 

THE DIRECTORS ARE AUTHORIZED TO SIGN ON BEHALF OF THE COMPANY.

 

SHAREHOLDERS / PARTNERS:

 

 

 

EMS PARTICIPAÇÕES S/A

99,99%

GERMED FARMACEUTICA LTDA

0,01%

 

AFFILIATES / SUBSIDIARIES:

 

 

 

LEGRAND PHARMA INDUSTRIA FARMACÊUTICA LTDA

99,00%

TOPZ INDUSTRIA E COMERCIO DE COSMÉTICOS LTDA

99,00%

GERMED FARMACÊUTICA LTDA

99,00%

EMS SIGMA FARMA LTDA

99,00%

SIGMA FARMA EMS, LLC

100,00%

 

COMPANY'S BACKGROUND

 

THE HISTORY OF EMS SIGMA PHARMA GROUP STARTS IN 1964, IN THE CITY OF SANTO ANDRÉ, WHEN THE PHARMACY CALLED SANTA CATARINA WAS ESTABLISHED BY EMILIANO SANCHEZ. AFTER 13 YEARS OF HARD WORK, DEDICATION AND GROWING, THE SMALL PHARMACY WAS TRANSFORMED INTO THE LABORATORY CALLED EMS.

 

DURING THE FOLLOWING YEARS, AS PART OF THEIR EXPANSION STRATEGY, THE LABORATORIES LEGRAND AND NOVAQUÍMICA WERE PURCHASED, FURTHER TO THE EXPANSION OF THE PRODUCTS LINE AND THE SEGMENT OF ACTIVITY, COMPLETING THE COMPANY'S PORTFOLIO.

 

CURRENTLY, THE GROUP IS COMPOSED BY THE COMPANIES EMS, LEGRAND, SIGMA PHARMA AND NATURE'S, ACTING IN THE PHARMACEUTICAL, GENERIC, CONSUME, HOSPITAL AND PERSONAL HYGIENE SEGMENTS. THE GROUP HAS AS HIGHLIGHT IT PIONEER CONDITION WITH GENERIC MEDICATIONS, BEING THE FIRST COMPANY TO RECEIVE THE APPROVAL OF ANVISA TO MANUFACTURE AND MERCHANDISE THE MEDICATION CALLED CYCLOSPORINE, WHICH IS DESTINED TO AVOID THE REJECTION OF TRANSPLANT ORGANS.

 

ONE OF THE LARGEST COMPANIES WITH ASSETS CAPITAL BEING 100% NATIONAL, IN 39 YEARS OF ACTIVITY IN THE BRAZILIAN MARKET, REACHED THE 11TH PLACE IN THE PHARMACEUTICAL INDUSTRIES RANKING (SOURCE: IMS HEALTH, 2002).

 

THE GROUP HAS TWO PRODUCTION UNITS LOCATED IN SÃO BERNARDO DO CAMPO AND HORTOLÂNDIA, SP, BEING THE LAST ONE THE MOST UPDATED COMPANY OF LATIN AMERICA, STRUCTURED ACCORDING TO THE STANDARDS ESTABLISHED BY THE FDA (FOOD AND DRUG ADMINISTRATION).

 

WITH 2,800 EMPLOYEES DISTRIBUTED IN THE ADMINISTRATION, COMMERCIAL AND INDUSTRIAL AREAS, THE EMS SIGMA PHARMA GROUP MANUFACTURES AND MERCHANDISE FOR ALL THE COUNTRY MORE THAN 350 PRODUCTS, ALL OF THEM MANUFACTURED UNDER THE MOST STRICT QUALITY STANDARDS, CONTRIBUTING IN THIS WAY TO IMPROVE THE HEALTH AND QUALITY OF LIFE OF ALL BRAZILIANS

 

ON DECEMBER 17, 2002 THE SUBJECT COMPANY CHANGED ITS CORPORATE NAME FROM EMS INDÚSTRIA FARMACÊUTICA LTDA TO THE CURRENT ONE.

 

FURTHER DETAILS ABOUT THE SUBJECT'S HISTORY ARE SO FAR NOT KNOWN.

 

PUBLIC INFORMATION:

 

LAWSUITS:

 

 

 

DATE:

COURT OF LAW:

 

4

STATE LAWSUITS

13/03/13

VARA DE BRASILIA/DF

3

MONITORY SUITS

07/07/09

2ª VARA DE HORTOLANDIA/SP

 

 

FINANCIAL INFORMATION

 

GENERAL BALANCE SHEETS AS OF 31/12/2012, 31/12/2011 AND 31/12/2010.

( FIGURES ARE IN THOUSANDS OF REAIS ).

 

ASSETS

 

 

 

CURRENT:

31/12/2012

31/12/2011

31/12/2010

 

 

 

 

CASH AND BANKS

61.619

11.406

10.338

CLIENTS

399.103

418.442

309.885

INVENTORY

218.712

207.773

147.183

OTHER CREDITS

8.249

3.634

2.711

INTERCOMPANY CREDITS

161.594

181.565

109.063

RECOVERABLE TAXES

2.863

13.398

11.778

 

----------------

----------------

----------------

TOTAL CURRENT ASSETS

852.140

836.218

590.958

 

LONG-TERM RECEIVABLES:

 

 

 

 

 

 

 

JUDICIAL DEPOSITS

14.961

13.074

8.241

DEFERRED TAXES

14.129

28.828

35.208

INTERCOMPANY CREDITS

 

 

79.464

RECOVERABLE TAXES

6.931

3.058

3.058

INVESTMENTS

21.733

17.904

14.846

OTHER CREDITS

2.640

2.640

2.640

 

----------------

----------------

----------------

TOTAL LONG-TERM RECEIVABLES

60.394

65.504

143.457

 

FIXED ASSETS:

 

 

 

 

 

 

 

INVESTMENTS

149.936

94.525

39.744

FIXED ASSETS

235.818

174.656

132.263

INTANGIBLE

3.479

3.697

3.038

 

----------------

----------------

----------------

TOTAL FIXED ASSETS

389.233

272.878

175.045

 

================

================

================

TOTAL ASSETS

1.301.767

1.174.600

909.460

 

LIABILITIES:

 

 

 

CURRENT:

31/12/2012

31/12/2011

31/12/2010

 

 

 

 

LOANS AND FINANCING

51.825

35.615

32.365

SUPPLIERS

132.654

121.659

64.529

INTERCOMPANY DEBTS

116.567

18.502

4.731

ACCOUNTS PAYABLE

26.358

8.292

8.549

INSTALLMENTS TAXES PAYABLE

10.617

14.598

12.469

INCOME TAX/SOCIAL CONTRIBUTION

21.553

108.427

24.970

TAX LIABILITIES

30.629

36.861

10.822

SOCIAL / LABOR OBLIGATIONS

36.352

27.910

23.015

 

----------------

----------------

----------------

TOTAL CURRENT LIABILITIES

426.555

371.864

181.450

 

LONG TERM LIABILITIES:

 

 

 

 

 

 

 

LOANS AND FINANCING

152.881

119.435

123.961

INSTALLMENTS TAXES PAYABLE

25.065

29.819

21.398

PROVISION FOR CONTINGENCIES

53.622

42.928

58.313

DEFERRED TAXES

 

8.560

429

OTHER

 

 

2.561

DEFERRED REVENUE

102.207

90.263

79.691

PROVISIONS

 

15.438

 

 

----------------

----------------

----------------

TOTAL LONG TERM LIABILITIES

333.775

306.443

286.353

 

NET EQUITY:

 

 

 

 

 

 

 

SHARE CAPITAL

221.708

221.708

221.708

CAPITAL RESERVES

164.019

164.019

164.019

PROFIT RESERVES

155.710

44.341

29.375

OTHER

 

66.225

26.555

 

----------------

----------------

----------------

TOTAL NET EQUITY

541.437

496.293

441.657

 

================

================

================

TOTAL LIABILITIES

1.301.767

1.174.600

909.460

 

PROFIT AND LOSS ACCOUNTS AS OF 31/12/2012, 31/12/2011 AND 31/12/2010.

( FIGURES ARE IN THOUSANDS OF REAIS ).

 

 

31/12/2012

31/12/2011

31/12/2010

 

 

 

 

NET SALES

1.635.486

1.636.924

1.213.283

(-) COST OF SOLD GOODS

591.991

511.662

444.871

 

----------------

----------------

----------------

GROSS PROFIT

1.043.495

1.125.262

768.412

OPERATING REVENUE (EXPENSE)

-643.645

-560.038

-433.523

FINANCIAL REVENUE(EXPENSE)

-41.441

-28.967

-8.271

 

----------------

----------------

----------------

OPERATIONAL PROFIT (LOSS)

358.409

536.257

326.618

CONTRIBUTION/INCOME TAX

-88.978

-182.243

-91.937

 

----------------

----------------

----------------

NET PROFIT (LOSS)

269.431

354.014

234.681

 

RATIOS:

31/12/2012

31/12/2011

31/12/2010

 

QUICK RATIO

1,49

 

1,69

 

2,45

 

CURRENT RATIO

2,00

 

2,25

 

3,26

 

ACCOUNTS RECEIVABLE TURNOVER

4,10

TIMES

3,91

TIMES

3,92

TIMES

DAYS' SALES IN RECEIVABLES

87,85

DAYS

92,03

DAYS

91,95

DAYS

INVENTORY TURNOVER

2,71

TIMES

2,46

TIMES

3,02

TIMES

ACCOUNTS PAYABLE PERIOD

80,67

DAYS

85,60

DAYS

52,22

DAYS

RETURN ON ASSETS

1,26

TIMES

1,39

TIMES

1,33

TIMES

SALES TURNOVER ON NET EQUITY

3,02

TIMES

3,30

TIMES

2,75

TIMES

NET WORTH TIE-UP

,44

 

,35

 

,30

 

INDEBTEDNESS

1,40

 

1,37

 

1,06

 

EQUITY RATIO

41,59

%

42,25

%

48,56

%

WORKING CAPITAL RATIO

99,77

%

124,87

%

225,69

%

GENERAL SOLVENCY

1,71

 

1,73

 

1,94

 

RETURN ON NET EQUITY

49,76

%

71,33

%

53,14

%

RETURN ON SALES (PROFIT MARGIN)

16,47

%

21,63

%

19,34

%

GROSS PROFIT MARGIN

63,80

%

68,74

%

63,33

%

OPERATIONAL RESULT

21,91

%

32,76

%

26,92

%

SALES TURNOVER ON LIABILITIES

3,83

TIMES

4,40

TIMES

6,69

TIMES

FOREIGN CURRENCY ON ASSETS

 

 

 

 

 

 

FOREIGN CURRENCY ON LIABILITIES

 

 

 

 

 

 

 

EXCHANGE RATE:

 

 

US$ 1,00 = R$ 2,01

 - OFFICIAL RATE ON 23/04/2013

US$ 1,00 = R$ 2,04

 - OFFICIAL RATE ON 31/12/2012

US$ 1,00 = R$ 1,87

 - OFFICIAL RATE ON 31/12/2011

US$ 1,00 = R$ 1,66

 - OFFICIAL RATE ON 31/12/2010

 

COMMENTS ON THE FINANCIAL INFORMATION:

 

FOLLOWS ATTACHED WORKSHEET WITH MAIN FINANCIAL RATIOS.

 

THE FIGURES AVAILABLE SHOW A NORMAL FINANCIAL STANDING. THE LEVEL OF INDEBTEDNESS IS HIGH BUT IT HAS HIGH LIQUIDITY RATIOS AND IMPORTANT WORKING CAPITAL. IT ALSO SHOWS HIGH SALES AND PROFITABILITY.

 

IT IS WORTH TO COMMENT THAT THE SUBJECT HAS A HIGH FINANCIAL STRENGTH AND SO FAR IT OPERATES NORMALLY BEING NOT LIKELY TO FACE FINANCIAL PROBLEMS.

 

REAL ESTATE:

OWNED PREMISES ARE VALUED AT R$ 727.800,00

 

DETAIL OF OWNED REAL ESTATE:

 

QUANTITY:

1

TYPE:

OTHERS

VALUE:

R$ 110.400,00

ADDRESS:

AV. ARTHUR DE QUEIROZ S/N - CASA BRANCA EM SANTO ANDRÉ/SP

 

 

QUANTITY:

1

TYPE:

BUILDING

VALUE:

R$ 736.000,00

ADDRESS:

AV. ARTHUR DE QUEIROZ, 905/915 - CASA BRANCA, EM SANTO ANDRÉ/SP

 

VEHICLES:

NOT AVAILABLE

 

MACHINES:

NOT AVAILABLE

 

INSURANCE

 

INSURANCE COMPANY:

MINAS-BRASIL SEGURADORA

COVERAGE:

ALL RISKS

VALUE:

R$ 18.567.680,00

 

 

BANKING REFERENCES

 

 

BRANCH/PHONE:

CITY:

BANCO ITAÚ S/A

0009  /  19 3735-9709

CAMPINAS/SP

BANCO DO BRASIL S/A

2900-9  /  19 3794-9023

CAMPINAS/SP

 

REMARKS: IN BRAZIL THE BANKS ARE PROHIBITED BY LAW TO PROVIDE INFORMATION OR ANY KIND OF COMMENTS ABOUT THEIR CLIENTS. DUE TO THIS LAW PROHIBITION WE ARE UNABLE TO PROVIDE ANY BANKING DETAILS.

 

ACCORDING TO THE CENTRAL BANK OF BRAZIL OFFICIAL REPORT, THE COMPANY HAS NO RETURNED CHECKS UP TO DATE. (IN THE TERMS OF "CIRCULAR 1682 BRAZILIAN CENTRAL BANK").

 

 

ACTIVITIES COMMENTS

 

THE SUBJECT IS ENGAGED IN THE MANUFACTURE AND TRADE OF PHARMACEUTICAL PRODUCTS.

 

IMPORT AND EXPORT:

 

IMPORTS FROM:

ITALY, GERMANY, FRANCE, CANADA, INDIA AND SWEDEN.

 

EXPORTS TO:

DOES NOT EXPORT.

 

MAIN CLIENTS:

 

 

 

 

 

DOMESTIC CLIENTS:

CITY:

PHONE:

DIST.DE DROGAS NORFARMA LTDA

ARAÇATUBA/SP

18 623-3645

DISTR. FARMACÊUTICA PANARELLO LTDA

GOIÂNIA/GO

62 3285-6611

DISTR. MEDICAMENTOS SANTA CRUZ LTDA

CURITIBA/PR

41 3316-2209

DISTR.DROGAS CENTRO OESTE LTDA.

CAMPO GRANDE/MS

67 382-6188

ITA REPRES. PRODS. FARMACÊUTICOS

SANTA BÁRBARA D´OESTE/SP

19 3459-4000

JAMYR VASCONCELOS S/A

RIO DE JANEIRO/RJ

21 2472-2828

PERFORMA DISTR. PRODS. FARMACÊUTICOS LTDA

RIACHO DAS PEDRAS/MG

21 3450-1416

UNIFARMA DISTRIBUISDORA FARMACEUTICA LTDA

IMPERATRIZ/MA

98 3525-3486

 

STAFF:

 

THE COMPANY HAS: 4500 EMPLOYEE(S)

 

 

CONCEPT AND FULFILMENT

 

THE SUBJECT IS AN OLD-ESTABLISHED COMPANY, OPERATING SINCE 1964 WITH A LEADING MARKET POSITION. IT HAS A HIGH AND GROWING SCALE OF ACTIVITIES AND AN EXCELLENT TRADE REPUTATION.

 

THE COMPANY HAS TRADE RELATIONS WITH SEVERAL SUPPLIERS IN BRAZIL. THE SUPPLIERS EXTEND CREDIT FACILITIES TO THE SUBJECT IN TERMS AND AMOUNTS ACCORDING TO THE COMPANY'S NEEDS AND SO FAR NO PAYMENT PROBLEMS ARE NOTED.

 

THE LAWSUITS REPORTED ARE NOT RELATED WITH TRADE DEBTS. THEY ARE RELATED TO TAX DEBTS THAT FOR ANY REASON THE COMPANY HAS NOT YET PAID. NEVERTHELESS WE POINT OUT THAT THE SAID LAWSUITS DO NOT AFFECT THE COMPANY'S TRADE REPUTATION.

 

MAIN SUPPLIERS:

 

 

 

 

 

DOMESTIC SUPPLIERS:

CITY:

PHONE:

ALLPLAS INDÚSTRIA.COM.PLÁSTICOS LTDA

CARAPICUIBA/SP

11 429-7443

BAFEMA S/A INDÚSTRIA E COMÉRCI0

SÃO PAULO/SP

11 246-4088

BOAINAIN DIOSTR. DE ALCOOL LTDA

OSASCO/SP

11 703-7111

CIA. UNIÃO REFINADORES AÇÚCAR E CAFÉ

SÃO PAULO/SP

11 291-6111

COLORCON DO BRASIL LTDA

COTIA/SP

11 4617-8640

ESQYEMA IND.COM.EMBALAGENS LTDA

OSASCO/SP

11 703-1577

FENIL QUÍMICA LTDA

SÃO PAULO/SP

11 548-9332

HENRIFARMA PRODS.QUI.FARM. LTDA

SÃO PAULO/SP

11 549-9933

M. CASSAB COMERCIO E INDUSTRIA LTDA

SÃO PAULO/SP

11 2162-7788

PRODUTOS ROCHE QUÍM. FARMACÊUTICA S/A

SÃO PAULO/SP

11 268-7022

VEDAT TAMPAS HERMETICAS LTDA

EMBU/SP

11 2133-1212

VITROSUL IND.COM.VIDORS LTDA

EMBÚ/SP

11 494-6877

VULCAN MARTERIAL PLÁSTICO S/A

RIO DE JANEIRO/RJ

21 3362-2037

WHEATON DO BRASIL S/A

SÃO BERNARDO CAMPO/SP

11 451-4433

 

PAYMENT HISTORY:

 

8 SUPPLIERS REPORTED PAYMENTS:

   TOTAL AMOUNT:  R$ 4.533.134,00

 

AMOUNT OF INVOICES PAID: 62

TOTAL OF PROMPT PAYMENTS: 99,9%

TOTAL OF DELAYED PAYMENTS: 0,1%

 

HIGHEST INVOICE: R$ 792.429,00

HIGHEST CREDIT: R$ 792.429,00

 

OUTSTANDING INVOICES DUE WITHIN THE NEXT 30 DAYS:

 

---------------------------

SUPPLIERS:

INVOICES:

TOTAL AMOUNT:

DUE WITHIN 30 DAYS

2

8

R$ 88.923,39

 

 

FINAL OPINION

 

THE SUBJECT IS A WELL-ESTABLISHED COMPANY IN BUSINESS FOR SEVERAL YEARS. UP TO DATE IT HAS CLEAR TRADE HISTORY AND GOOD PAYMENT PERFORMANCE.

 

BASED ON THE OVERALL INFORMATION AVAILABLE IT IS BELIEVED THAT GOOD TRADE RELATIONS MAY BE ESTABLISHED. CREDIT FACILITIES MAY BE EXTENDED WITHIN TERMS AND AMOUNTS ADEQUATE TO THE COMPANY'S SIZE AND FINANCIAL STRENGTH.

 

 

 


 

EMS S/A

 

 

 

 

 

 

BALANCE SHEET ANALYSIS

FIGURES ARE IN THOUSANDS OF REAIS

 

 

 

 

31/12/2012

 

31/12/2011

 

31/12/2010

 

ASSETS

 

%

 

%

 

%

Current Assets

 $                 852,140

65.46

 $                 836,218

71.19

 $             590,958

64.98

Fixed Assets

 $                 389,233

29.90

 $                 272,878

23.23

 $             175,045

19.25

TOTAL ASSETS

 $              1,301,767

100.00

 $              1,174,600

100.00

 $             909,460

100.00

LIABILITIES

 

 

 

 

 

 

Current Liabilities

 $                 426,555

32.77

 $                 371,864

31.66

 $             181,450

19.95

Long-Term Liabilities

 $                 333,775

25.64

 $                 306,443

26.09

 $             286,353

31.49

TOTAL LIABILITIES

 $                 760,330

58.41

 $                 678,307

57.75

 $             467,803

51.44

Deferred Income

 $                            -  

0.00

 $                            -  

0.00

 $                        -  

0.00

Net Equity

 $                 541,437

41.59

 $                 496,293

42.25

 $             441,657

48.56

TOTAL LIABILITIES + NET EQUITY

 $              1,301,767

100.00

 $              1,174,600

100.00

 $             909,460

100.00

PROFIT AND LOSS ACCOUNTS

 

 

 

 

 

 

Net Sales

 $              1,635,486

100.00

 $              1,636,924

100.00

 $          1,213,283

100.00

Costs

 $                 591,991

36.20

 $                 511,662

31.26

 $             444,871

36.67

Gross Profit

 $              1,043,495

63.80

 $              1,125,262

68.74

 $             768,412

63.33

Operating expenses

 $                (643,645)

-39.35

 $                (560,038)

-34.21

 $            (433,523)

-35.73

operational Result

 $                 358,409

21.91

 $                 536,257

32.76

 $             326,618

26.92

Net Profit (loss)

 $                 269,431

16.47

 $                 354,014

21.63

 $             234,681

19.34

COMPLEMENTARY DATA

 

 

 

 

 

 

Inventory

 $                 218,712

 

 $                 207,773

 

 $             147,183

 

Accounts receivable

 $                 399,103

 

 $                 418,442

 

 $             309,885

 

Accounts Payable

 $                 132,654

 

 $                 121,659

 

 $               64,529

 

Property, plant and equipment

 $                 235,818

 

 $                 174,656

 

 $             132,263

 

Purchases

 $                 389,233

 

 $                 272,878

 

 $             175,045

 

Financial Expenses

 $                  (41,441)

 

 $                  (28,967)

 

 $                (8,271)

 

Foreign Currency Assets

 

 

 

 

 

 

Foreign Currency Liabilities

 

 

 

 

 

 

Working Capital

 $                 425,585

 

 $                 464,354

 

 $             409,508

 

RATIOS:

 

 

 

 

 

 

QUICK RATIO

                           1.48

 

                           1.69

 

                       2.45

 

CURRENT RATIO

                           2.00

 

                           2.25

 

                       3.26

 

ACCOUNTS RECEIVABLE TURNOVER

                           4.10

times

                           3.91

times

                       3.92

times

DAYS' SALES IN RECEIVABLES

                         87.85

days

                         92.03

days

                     91.95

days

INVENTORY TURNOVER

                           2.71

times

                           2.46

times

                       3.02

times

ACCOUNTS PAYABLE PERIOD

                         80.67

days

                         85.60

days

                     52.22

days

RETURN ON ASSETS

                           1.26

times

                           1.39

times

                       1.33

times

SALES TURNOVER ON NET EQUIY

                           3.02

times

                           3.30

times

                       2.75

times

NET WORTH TIE-UP

                           0.44

 

                           0.35

 

                       0.30

 

ENDEBTEDNESS

                           1.40

 

                           1.37

 

                       1.06

 

EQUITY RATIO

                         41.59

%

                         42.25

%

                     48.56

%

WORKING CAPITAL RATIO

                         99.77

%

                       124.87

%

                   225.69

%

GENERAL SOLVENCY

                           1.71

 

                           1.73

 

                       1.94

 

RETURN ON NET EQUITY

                         49.76

%

                         71.33

%

                     53.14

%

RETURN ON SALES (PROFIT MARGIN)

                         16.47

%

                         21.63

%

                     19.34

%

GROSS PROFIT MARGIN

                         63.80

%

                         68.74

%

                     63.33

%

OPERATIONAL RESULT

                         21.91

%

                         32.76

%

                     26.92

%

SALES TURNOVER ON LIABILITIES

                           3.83

times

                           4.40

times

                       6.69

times

FOREIGN CURRENCY ON ASSETS

                               -  

%

                               -  

%

                           -  

%

FOREIGN CURRENCY ON LIABILITIES

                               -  

%

                               -  

%

                           -  

%

 

 

 

 

 

 

 

 

 

 


FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.54.17

UK Pound

1

Rs.82.99

Euro

1

Rs.70.62

 

INFORMATION DETAILS

 

Report Prepared by :

MNL

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.